INDIANAPOLIS — Roche on Tuesday announced that the Accu-Chek Aviva Expert system is now available by prescription. The device represents a significant advancement in blood-glucose meter technology for ...
July 2, 2010 (Orlando, Florida) — Children with type 1 diabetes can have their pizza and eat it, too, if they calculate their premeal insulin dose according to carbohydrate, fat, and protein intake ...
The FDA has cleared Glooko's Mobile Insulin Dosing System. Glooko's new system calculates long-acting insulin dosages and sends Type 2 diabetes patients reminders on their cellphones. Long-acting ...
Roche announced that the ACCU-CHEK Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the US Food and Drug Administration (FDA), is ...
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice To view the multimedia ...
Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared ...
First Glucose Meter with Insulin Calculator Available Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator. Roche announced the ...
SINGAPORE: Tan Tock Seng Hospital (TTSH) and biomedical technology company Buzud are working on an AI or artificial intelligence-enabled tool in an app to help diabetes patients accurately calculate ...
WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System, ...
Not everyone with type 2 diabetes has to take insulin. But if you do, you and your doctor will decide the best schedule and insulin dose for you. You may also need to figure out some dosages on your ...
WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results